Abstract:Objective:To design and synthesize the triazole derivatives with the side chain containing tert-butyl and 4-substitued-piperazin-1-yl and to investigate their antifungal activities in vitro. Methods: The triazole derivatives were synthesized through several steps using 3, 3-dimethylbutyryl chloride as the starting material. All the target compounds were confirmed by 1HNMR to be 1-(1H-1, 2, 4-triazol-1-yl)-2-(3, 3-dimethyl)-3-(4-substituted)-piperazin-1-yl-2-propanols. Candida albicans (ATCC76615), Cryptococcus neoformans (ATCC32609), Candida tropicalis, Candida parapsilosis, Trichophyton rubrum, Microsporum lauosum, Fonsecaea compacta, and Aspergillus fumigatus were used to test the anti-fungal activities of the target compounds in vitro according to the National Committee for Clinical Laboratory Standards (NCCLS). Results: Eleven target compounds were obtained and all of them were firstly reported. We also found that all the 11 compounds had certain antifungal activities against the 8 tested strains. Conclusion: Compound 9 has a better effect against Cryptococcus neoformans than fluconazole and itraconazole; compound 8 has a better effect against Aspergillus fumigatus than fluconazole; these two compounds deserve further study.

New Triazole Derivatives Containing Substituted 1,2,3-Triazole Side Chains: Design, Synthesis and Antifungal Activity

Design, synthesis and antifungal activity of novel triazole derivatives containing substituted 1,2,3-triazole-piperdine side chains.

Design, synthesis, and in vitro evaluation of novel antifungal triazoles containing substituted 1,2,3-triazole-methoxyl side chains

Design, synthesis, and antifungal activity of novel conformationally restricted triazole derivatives.

Structure-based design, synthesis, and antifungal activity of new triazole derivatives.

Design, synthesis, and biological evaluation of novel 1, 2, 4-triazole derivatives as antifungal agent

Design, synthesis and in vitro biological studies of novel triazoles with potent and broad-spectrum antifungal activity

Design, synthesis and <i>in vitro</i> biological studies of novel triazoles with potent and broad-spectrum antifungal activity

Design, Synthesis, and In Vitro and In Vivo Antifungal Activity of Novel Triazoles Containing Phenylethynyl Pyrazole Side Chains

[Synthesis and Antifungal Activity of Novel Triazole Antifungal Agents].

Synthesis and Antifungal Activity of Triazole Derivatives with Side Chain Containing Tert-Butyl and 4-Substitued-piperazin-1-yl

Design, synthesis and molecular docking studies of novel triazole as antifungal agent.

Design, synthesis, and antifungal activities of novel triazole derivatives containing the benzyl group.

Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives.

Triazole Derivatives with Improved in Vitro Antifungal Activity over Azole Drugs

Design, Synthesis, and in Vitro Evaluation of Novel Triazole Analogues Featuring Isoxazole Moieties As Antifungal Agents.

[Synthesis and Antifungal Activity of 1-(1,2,4-triazolyl-1h-1-yl)-2-(2,4-diflurophenyl)-3-(4-substituted Benzyl-1-piperazinyl)-2-propanols].

Synthesis, In Vitro Biological Evaluation, and Molecular Docking of New Triazoles as Potent Antifungal Agents.

Synthesis, in Vitro Evaluation and Molecular Docking Studies of New Triazole Derivatives As Antifungal Agents.

Molecular Docking, Design, Synthesis and Antifungal Activity Study of Novel Triazole Derivatives Containing the 1,2,3-Triazole Group

Synthesis and biological evaluation of triazole derivatives as potential antifungal agent.